Marcos Rodríguez-Esteban
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcos Rodríguez-Esteban has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Alejandro Quijada-Fumero
Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
2 shared publicationsAntonio Trugeda-Padilla
Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España
2 shared publicationsCristina Mesa del Castillo-Payá
Servicio de Oncología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España
2 shared publicationsLeidimar Carballo-Arzola
Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
2 shared publications- Luis Álvarez-Acosta
Department of Cardiology, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain
2 shared publications Marcos Farrais-Villalba
Servicio de Cardiología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España
2 shared publications
Latest Publications
- Open Access
- 25 January 2021
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 34 (2) , 100-106
Evolution of antimicrobial resistance and mortality in Staphylococcus aureus endocarditis during 15 years in a university hospital
Introduction. One of the most aggressive microorganisms in infective endocarditis (IE) is Staphylococcus aureus. We analyse the resistance of S. aureus to antibiotics and its impact on the clinical course of IE in a recent 15-year period. Methods. Retrospective study of patients with IE in a university hospital from 2005 to 2019. Bivariate and multivariate analysis of severity at admission, comorbidities, minimum inhibitory concentrations (MIC) and mortality. Results. Of the 293 IE cases, 66 (22.5%) were due to S. aureus, and 21 (7.2%) were methicillin-resistant S. aureus (MRSA). The prevalence of strains with a MIC to vancomycin ≥ 1mg/L increased from 4.8% to 63.6% (p <0.001) and the cases of MRSA from 38 to 27.3% (p = 0.045). Older age (p= 0.02), comorbidity (p <0.01) and nosohusial origin (p = 0.01), were factors associated with MRSA. But the antimicrobial resistance and severity on admission were not associated with exitus; predictive factors were the right-sided IE (OR = 0.08; 95% CI: 0.01-0.51), comorbidities (OR per Charlson index point = 1.30; 95% CI: 1.01-1.69) and creatinine on admission (OR per mg / dL = 1.56; 95% CI = 1.01- 2.35; p = 0.04). Conclusion. We have experienced an increase in IE cases with MIC to vancomycin ≥ 1mg/L, without significant variation in infections due to MRSA. Antimicrobial resistance was not associated with mortality, but comorbidity and left involvement were predictive factors.
- 25 January 2021
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 34 (2) , 100-106
Open AccessEvolution of antimicrobial resistance and mortality in Staphylococcus aureus endocarditis during 15 years in a university hospital
Introduction. One of the most aggressive microorganisms in infective endocarditis (IE) is Staphylococcus aureus. We analyse the resistance of S. aureus to antibiotics and its impact on the clinical course of IE in a recent 15-year period. Methods. Retrospective study of patients with IE in a university hospital from 2005 to 2019. Bivariate and multivariate analysis of severity at admission, comorbidities, minimum inhibitory concentrations (MIC) and mortality. Results. Of the 293 IE cases, 66 (22.5%) were due to S. aureus, and 21 (7.2%) were methicillin-resistant S. aureus (MRSA). The prevalence of strains with a MIC to vancomycin ≥ 1mg/L increased from 4.8% to 63.6% (p <0.001) and the cases of MRSA from 38 to 27.3% (p = 0.045). Older age (p= 0.02), comorbidity (p <0.01) and nosohusial origin (p = 0.01), were factors associated with MRSA. But the antimicrobial resistance and severity on admission were not associated with exitus; predictive factors were the right-sided IE (OR = 0.08; 95% CI: 0.01-0.51), comorbidities (OR per Charlson index point = 1.30; 95% CI: 1.01-1.69) and creatinine on admission (OR per mg / dL = 1.56; 95% CI = 1.01- 2.35; p = 0.04). Conclusion. We have experienced an increase in IE cases with MIC to vancomycin ≥ 1mg/L, without significant variation in infections due to MRSA. Antimicrobial resistance was not associated with mortality, but comorbidity and left involvement were predictive factors.
- 1 February 2018
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 36 (2) , 72-77
Endocarditis infecciosa en pacientes con enfermedades oncológicas
- 1 February 2018
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 36 (2) , 72-77
Endocarditis infecciosa en pacientes con enfermedades oncológicas
- 1 February 2018
- Published by Elsevier in Enfermedades Infecciosas y Microbiologia Clinica (English Ed.)
- Vol. 36 (2) , 72-77
Infective endocarditis in patients with oncological diseases
- 1 February 2018
- Published by Elsevier in Enfermedades Infecciosas y Microbiologia Clinica (English Ed.)
- Vol. 36 (2) , 72-77
Infective endocarditis in patients with oncological diseases
- 1 January 2016
- Published by Elsevier in Revista Clínica Española
- Vol. 216 (1) , 15-18
Cumplimiento de las guías de la Sociedad Europea de Cardiología y morbimortalidad por endocarditis infecciosa
- 1 January 2016
- Published by Elsevier in Revista Clínica Española
- Vol. 216 (1) , 15-18
Cumplimiento de las guías de la Sociedad Europea de Cardiología y morbimortalidad por endocarditis infecciosa
- 1 July 2015
- Published by Elsevier in Reumatología Clínica
- Vol. 11 (4) , 258-259
Arteritis y seudoaneurisma coronarios en la enfermedad de Behçet: una causa infrecuente de infarto de miocardio
- 1 July 2015
- Published by Elsevier in Reumatología Clínica
- Vol. 11 (4) , 258-259
Arteritis y seudoaneurisma coronarios en la enfermedad de Behçet: una causa infrecuente de infarto de miocardio
- 1 January 2015
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 33 (1) , 70-71
Mortalidad en pacientes con endocarditis infecciosas atendidos en 2 hospitales dotados de cirugía cardiaca. Réplica
- 1 January 2015
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 33 (1) , 70-71
Mortalidad en pacientes con endocarditis infecciosas atendidos en 2 hospitales dotados de cirugía cardiaca. Réplica
- 1 May 2014
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 32 (5) , 297-301
Endocarditis infecciosa en 2 hospitales universitarios españoles que difieren en su localización y en la presencia de servicio quirúrgico
- 1 May 2014
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 32 (5) , 297-301
Endocarditis infecciosa en 2 hospitales universitarios españoles que difieren en su localización y en la presencia de servicio quirúrgico